The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

EMBO Journal

Volumn 18, Issue 6, 1999, Pages 1571-1583

  Cheng, Mangeng ^a   Olivier, Paul ^b   Diehl, J Alan ^a   Fero, Matthew ^b   Roussel, Martine F ^a   Roberts, James M ^b   Sherr, Charles J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

CDK4; Cell cycle; D type cyclins; p21(Cip1); p27(Kip1)

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; MITOGENIC AGENT; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL NUCLEUS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 0033559264     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.6.1571     Document Type: Article

References (82)

1. 1 phase in primary human T lymphocytes. J. Biol. Chem., 268, 4113-4119.
2. Kip1. Mol. Cell. Biol., 17, 3850-3857.
3. ras mutants and c-Els-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem., 270, 23589-23597.
4. Alessandrini, A., Chiaur, D.S. and Pagano, M. (1997) Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia, 11, 342-345.
5. Aprelikova, O., Xiong, Y. and Liu, E.T. (1995) Both p16 and p21 families of the cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem., 270, 18195-18197.
6. Baldin, Y., Lukas, J., Marcote, M.J., Pagano, M. and Draetta, G. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev., 7, 812-821.
7. Bates, S., Parry, D., Bonetta, L., Vousden, K., Dickson, C. and Peters, G. (1994) Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene, 9, 1633-1640.
8. Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem., 272, 25863-25872.
9. Boudewijn, M., Burgering, Th. and Coffer, P.J. (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature, 376, 599-602.
10. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T. and Hannon, G.J. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 377, 552-557.
11. INK4. Mol. Cell. Biol., 15, 2682-2688.
12. Chen, C. and Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752.
13. Chen, J., Jackson, P.K., Kirschner, M.W. and Dutta, A. (1995) Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature, 374, 386-388.
14. CIP1. Mol. Cell. Biol., 16, 4673-4682.
15. Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl Acad. Sci. USA, 95, 1091-1096.
16. Cross, D.A.E., Alessi, D.R., Cohen, P., Andjelkovich, M. and Hemmings, B.A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785-789.
17. Dai, K., Kobayashi, R. and Beach, D. (1996) Physical interaction of mammalian CDC37 with CDK4. J. Biol. Chem., 271, 22030-22034.
18. 1 checkpoint control. Cell, 82, 675-684.
19. Diehl, J.A. and Sherr, C.J. (1997) A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase-4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol., 17, 7362-7374.
20. Diehl, J.A., Zindy, F. and Sherr, C.J. (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its, rapid degradation via the ubiquitin-proteasome pathway. Genes Dev., 11, 957-972.
21. Diehl, J.A., Cheng, M., Roussel, M.F. and Sherr, C.J. (1998) Glycogen Synthase Kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev., 12, 3499-3511.
22. Dudek, H., Datta, S.R., Franke, T.F., Birnbaum, M.J., Yao, R., Cooper, G.M., Segal, R.A., Kaplan, D.A. and Greenberg, M.E. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 275, 661-665.
23. 1 arrest. Cell, 76, 1013-1023.
24. El-Deiry, W.S. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
25. Elledge, S.J. and Harper, J.W. (1994) CDK inhibitors: on the threshold of check points and development. Curr. Opin. Cell Biol., 6, 847-852.
26. Fantl, V., Stamp, G., Andrews, A., Rosewell, I. and Dickson, C. (1995) Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9, 2364-2372.
27. Firpo, E.J., Koff, A., Solomon, M.J. and Roberts, J.M. (1994) Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol., 14, 4889-4901.
28. Franke, T.F., Yang, T.O., Chan, K., Datta, A., Kazlauskas, D.K., Morrison, D.K., Kaplan, D.R. and Tsichlis, P.N. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell, 81, 727-736.
29. Franke, T.F., Kaplan, D.R., Cantley, L.C. and Toker, A. (1997) Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science, 275, 665-668.
30. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8, 2939-2952.
31. INK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature, 371, 257-261.
32. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Eliedge, S.J. (1993) The p21 cdk-inleracting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
33. Hatakeyama, M., Brill, J.A., Fink, G.R. and Weinberg, R.A. (1994) Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev., 8, 1759-1771.
34. Hirai, H., Roussel, M.F., Kato, J.-Y., Ashmun, R.A. and Sherr, C.J. (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases. Mol. Cell. Biol., 15, 2672-2681.
35. Kamijo, T., Zindy, F., Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., Grosveld, G. and Sherr, C.J. (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell, 91, 649-659.
36. Kip1) of cyclin-dependent kinase-4 activation. Cell, 79, 487-496.
37. Kelly, B.L., Wolfe, K.G. and Roberts, J.M. (1998) Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein. Proc. Natl Acad. Sci. USA, 95, 2535-2540.
38. Kerkhoff, E. and Rapp, U.R. (1997) Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol., 17, 2576-2586.
39. Kitagawa, M. et al. (1996) The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J., 15, 7060-7069.
40. Klinghoffer, R.A., Duckworth, B., Valius, M., Cantley, L. and Kazlauskas, A. (1996) Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence ras activity. Mol. Cell. Biol., 16, 5905-5914.
41. Koh, J., Enders, G.H., Dynlacht, B.D. and Harlow, E. (1995) Tumour-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature, 375, 506-510.
42. Krude, T., Jackman, M., Pines, J. and Laskey, R.A. (1997) Cyclin/cdk-dependent initiation of DNA replication in a human cell-free system. Cell, 88, 109-119.
43. LaBaer, J., Garrett, M.D., Stevenson, L.F. Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. and Harlow, E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11, 847-862.
44. MAPK pathway. J. Biol. Chem., 271, 20608-20616.
45. Kip1 in neurons. Proc. Natl Acad. Sci. USA, 93, 3259-3263.
46. WAF-1 gene activities. Mol. Biol. Cell, 16, 1786-1793.
47. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G. and Bartek, J. (1995) Retinoblastoma protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature, 375, 503-506.
48. Lundberg, A.S. and Weinberg, R.A. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-CDK complexes. Mol. Cell. Biol., 18, 753-761.
49. CIP1. Nature, 375, 159-161.
50. Mahony, D., Parry, D.A. and Lees, E. (1998) Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene, 13, 603-611.
51. Matsuoka, M., Kato, J., Fisher, R.P., Morgan, D.O. and Sherr, C.J. (1994) Activation of cyclin-dependent kinase-4 (CDK4) by mouse MO15-associated kinase. Mol. Cell. Biol., 14, 7265-7275.
52. 1 phase of the cell cycle. Cell, 65, 701-713.
53. 1 cyclins. Cell, 71, 323-334.
54. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J. and Kato, J.-Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14, 2066-2076.
55. ink4 requires functional retinoblastoma protein. Proc. Natl Acad. Sci. USA, 92, 6289-6293.
56. Meyerson, M. and Harlow, E. (1994) Identification of a G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14, 2077-2086.
57. Mittnacht, S., Lees, J.A., Desai, D., Harlow, E., Morgan, D.O. and Weinberg, R.A. (1994) Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J., 13, 118-127.
58. Sdil/CIP1/WAF1. EMBO J., 14, 555-563.
59. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature, 372, 570-573.
60. INK4/MTS1 tumour suppressor gene product. EMBO J., 14, 503-511.
61. Pear, W.S., NoPan, M.L., Scott, M.L. and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA, 90, 8392-8396.
62. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
63. Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev., 11, 492-503.
64. Russo, A.A., Jeffrey, P.D., Patten, A.K., Massagué, J. and Pavletich, N.P. (1996) Crystal structure of the p27Kip1 cyclin-dependent kinase inhibitor bound to the cyclin A-cdk2 complex. Nature, 382, 325-331.
65. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
66. Sheaff, R., Groudine, M., Gordon, M., Roberts, J. and Clurman, B. (1997) Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev., 11, 1464-1478.
67. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
68. 1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
69. Sicinski, P. et al. (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82, 621-630.
70. Sicinski, P. et al. (1996) Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature, 384, 470-471.
71. Soos, T.J. et al. (1996) Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ., 7, 135-146.
72. Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev., 10, 1491-1502.
73. Stillman, B. (1996) Cell cycle control of DNA replication. Science, 274, 1659-1664.
74. 1 cyclin/ cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
75. 1 cyclins. Hybridoma, 13, 37-44.
76. Vanhaesebroeck, B., Leevers, S.J., Panayotou, G. and Waterfield, M. (1997) Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Binchem. Sci., 22, 267-272.
77. Kip1. EMBO J., 16, 5334-5344.
78. 1 phase. Biochem. J., 326, 61-68.
79. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
80. Winston, J.T., Coats, S.R., Wang, Y.-Z. and Pledger, W.J. (1996) Regulation of the cell cycle machinery by oncogenic ras. Oncogene, 12, 127-134.
81. Zhang, H., Hannon, G.J. and Beach, D. (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8, 1750-1758.
82. INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene, 15, 203-211.